CombiMatrix Diagnostics is a CLIA -certified & CAP- accredited commercial clinical laboratory located in Irvine, California. We offer DNA-based genomic testing services in the areas of 1.) Prenatal and Pediatric developmental disorders and 2.) Oncology.
We turn important discoveries in human genetics into diagnostic, prognostic and predictive tests that inform physicians, patients and families about specific diseases and clinical manifestations that previously went undetected by older technologies. Such efforts have unlocked critical knowledge that provides clarity along the pathway of patient care.
CombiMatrix Diagnostics has established itself as an industry leader in microarray-based clinical testing via our core team of arrayCGH-pioneering physicians, scientists and technicians and our commitment to both client and patient-focused service.
Recent recommendations from groups such as the American College of Medical Genetics (ACMG) have positioned our DNAarray™ testing as a first line option for the detection and clarification of prevalent developmental disorders such as Autism.
Since entering the Oncology testing market in 2007, we have lead the industry in the implementation of clinical genomic profiling services for hematological malignancies and solid tumors.
Strategic Partnerships – CombiMatrix Diagnostics seeks affiliations with other laboratories and pathology groups that would like to offer our testing services to their own physician and patient populations.
We will empower physicians to positively impact patient care through the delivery of innovative molecular-based clinical laboratory services.
CombiMatrix Diagnostics is a wholly owned subsidiary of CombiMatrix Corporation, a publicly traded company (symbol: CBMX).
For more information, contact us today.